Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BYExperimental and Molecular Pathology

SARS-CoV-2 ORF7a induces cytotoxicity associated with AP-1 signaling and ferroptosis-related responses

  1. 1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  2. 2Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  3. 3Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Corresponding author at: Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose accessory proteins have incompletely understood roles in cellular injury. Bioinformatic analysis identified putative N-terminal signal peptides in ORF7a and ORF8. We characterized their expression, subcellular localization, and cytopathic effects in vitro. EGFP-tagged ORF7a and ORF8 showed intracellular ER–Golgi-associated distributions, and untagged ORF7a showed Golgi-associated localization. ORF7a, but not ORF8, induced prominent cytotoxicity in HEK293T cells, as assessed by real-time cell analysis and Annexin V/PI staining. Transcriptomic profiling identified changes in stress-, cell-death-, and ferroptosis-related genes. Ferrostatin-1 attenuated ORF7a-associated cytotoxicity, consistent with ferroptosis-related mechanisms. Mutation of the C-terminal ER retrieval motif (ORF7a-ARA) altered subcellular distribution and attenuated cytotoxicity and cFos/cJun accumulation. The AP-1 inhibitor T-5224 also attenuated cytotoxicity. Additional experiments demonstrated ORF7a localization in A549 cells and extended selected cytotoxicity and inhibitor-response findings to HK-2 cells. In HK-2 cells, ORF7a increased cJun abundance and reduced SLC7A11 and HO-1 protein levels. Together, these findings link the ER retrieval motif to ORF7a-associated cellular injury and support AP-1 involvement and the presence of ferroptosis-related features. Clinical trial number: not applicable.

Related

  1. Hydroxychloroquine-induced cytotoxicity in ARPE-19 cells involves PI3K/AKT-associated signaling: network toxicology and functional validation
    Lan Lin, Yunhao Zhou, Guanghui Liu +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
  2. Mixture-Dependent Toxicity of E-Cigarette Constituents: Cytotoxicity, Inflammation, and DNA-Repair-Associated Protein Responses in Bronchial Epithelial Cells.
    Ehsanul Kabir, Joshua Furst, Thivanka Muthumalage
    ToxicsPeer-reviewedCC BYFull textOncologyEurope PMC
  3. BL-DVDMS-mediated photodynamic therapy induces oxidative response associated with cellular senescence via p53/GADD45A signaling in lung cancer
    Xing Li, Minghai Ma, Yibo Mei +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefDOAJ
  4. Chronic exposure to the tire-wear contaminant 6-PPDQ induces senescence-associated biomarkers and neurobehavioral deficits: Involvement of ABL1-p53-autophagy signaling
    Zejiang Ma, Manxue Bai, Chunmei Xia +2
    Ecotoxicology and Environmental SafetyPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  5. Orlistat Suppresses Small Intestinal Neuroendocrine Tumor Growth Through ATF3-Associated Stress and Ferroptosis-Related Responses—In Vitro and Cell Line Xenograft Evidence
    Xiangrui Zeng, Sixu Chen, Qin Long +7
    CancersPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
BibTeX
@article{chen2026sarscov2,
  title = {{SARS-CoV-2 ORF7a induces cytotoxicity associated with AP-1 signaling and ferroptosis-related responses}},
  author = {Chia-Hsin Chen and Ru-Fang Li and Yi-Hsiu Wu and Wei-Yu Chen},
  journal = {Experimental and Molecular Pathology},
  year = {2026},
  month = nov,
  doi = {10.1016/j.yexmp.2026.105095},
  url = {https://doi.org/10.1016/j.yexmp.2026.105095},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - SARS-CoV-2 ORF7a induces cytotoxicity associated with AP-1 signaling and ferroptosis-related responses
AU  - Chia-Hsin Chen
AU  - Ru-Fang Li
AU  - Yi-Hsiu Wu
AU  - Wei-Yu Chen
PY  - 2026
DA  - 2026/11/04
JO  - Experimental and Molecular Pathology
DO  - 10.1016/j.yexmp.2026.105095
UR  - https://doi.org/10.1016/j.yexmp.2026.105095
AB  - Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose accessory proteins have incompletely understood roles in cellular injury. Bioinformatic analysis identified putative N-terminal signal peptides in ORF7a and ORF8. We characterized their expression, subcellular localization, and cytopathic effects in vitro. EGFP-tagged ORF7a and ORF8 showed intracellular ER–Golgi-associated distributions, and untagged ORF7a showed Golgi-associated localization. ORF7a, but not ORF8, induced prominent cytotoxicity in HEK293T cells, as assessed by real-time cell analysis and Annexin V/PI staining. Transcriptomic profiling identified changes in stress-, cell-death-, and ferroptosis-related genes. Ferrostatin-1 attenuated ORF7a-associated cytotoxicity, consistent with ferroptosis-related mechanisms. Mutation of the C-terminal ER retrieval motif (ORF7a-ARA) altered subcellular distribution and attenuated cytotoxicity and cFos/cJun accumulation. The AP-1 inhibitor T-5224 also attenuated cytotoxicity. Additional experiments demonstrated ORF7a localization in A549 cells and extended selected cytotoxicity and inhibitor-response findings to HK-2 cells. In HK-2 cells, ORF7a increased cJun abundance and reduced SLC7A11 and HO-1 protein levels. Together, these findings link the ER retrieval motif to ORF7a-associated cellular injury and support AP-1 involvement and the presence of ferroptosis-related features. Clinical trial number: not applicable.
SN  - 1096-0945
ER  -